STAAR Surgical Co
STAA27.169USD
+0.009+0.03%
交易中 （美东）报价延迟15分钟
1.34B总市值
亏损市盈率 TTM
关于 STAAR Surgical Co 公司
STAAR Surgical Company 设计、开发、制造和销售用于眼部植入的晶状体以及用于将晶状体送入眼部的附件输送系统。这些晶状体为患者提供了视觉自由，减少或消除了对眼镜或隐形眼镜的依赖。该公司是全球矫正或屈光手术中使用的晶状体制造商。其产品销往约 75 个国家/地区，在日本、德国、西班牙、美国、加拿大、英国和新加坡设有直销渠道，在中国、韩国、印度、法国、比荷卢三国和意大利设有直销和独立分销渠道。该公司以其 EVO 系列晶状体营销和销售用于屈光手术以治疗近视的 ICL。该公司的 EVO 系列晶状体包括 EVO ICL、EVO+ ICL 和 EVO Visian ICL。该公司还营销和销售用于治疗远视的 ICL 晶状体，称为 Visian ICL。
公司简介
公司代码STAA
公司名称STAAR Surgical Co
上市日期Feb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
员工数量1157
证券类型Ordinary Share
年结日Feb 24
公司地址1911 Walker Ave
城市MONROVIA
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编91016
电话16263037902
网址https://www.staar.com/
公司代码STAA
上市日期Feb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
地区USD
名称
营收
占比
Others
18.02M
42.30%
Japan
11.39M
26.75%
South Korea
7.33M
17.22%
U. S.
5.46M
12.82%
China
389.00K
0.91%
业务
地区
业务USD
名称
营收
占比
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
Broadwood Capital, Inc.
27.39%
BlackRock Institutional Trust Company, N.A.
13.61%
The Vanguard Group, Inc.
8.88%
Soleus Capital Management, L.P.
6.05%
Armistice Capital LLC
5.70%
其他
38.38%
持股股东
持股股东
占比
Broadwood Capital, Inc.
27.39%
BlackRock Institutional Trust Company, N.A.
13.61%
The Vanguard Group, Inc.
8.88%
Soleus Capital Management, L.P.
6.05%
Armistice Capital LLC
5.70%
其他
38.38%
股东类型
持股股东
占比
Hedge Fund
48.69%
Investment Advisor
38.83%
Investment Advisor/Hedge Fund
15.21%
Research Firm
5.55%
Pension Fund
1.04%
Sovereign Wealth Fund
0.92%
Individual Investor
0.58%
Bank and Trust
0.35%
Venture Capital
0.09%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
2023Q1
670
50.91M
105.54%
-1.16M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Broadwood Capital, Inc.
13.55M
27.35%
+1.09M
+8.75%
Apr 22, 2025
BlackRock Institutional Trust Company, N.A.
7.01M
14.16%
-305.44K
-4.17%
Mar 31, 2025
The Vanguard Group, Inc.
5.41M
10.92%
-439.86K
-7.52%
Mar 31, 2025
Soleus Capital Management, L.P.
2.56M
5.17%
+2.56M
--
Mar 31, 2025
Armistice Capital LLC
3.00M
6.06%
+2.13M
+244.04%
Mar 31, 2025
Resona Asset Management Co., Ltd.
2.17M
4.38%
+669.43K
+44.62%
Mar 31, 2025
Yunqi Capital Limited
1.94M
3.91%
+1.17M
+152.48%
Mar 31, 2025
State Street Global Advisors (US)
1.99M
4.03%
-57.87K
-2.82%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.19M
2.4%
+14.77K
+1.26%
Mar 31, 2025
BofA Global Research (US)
953.61K
1.93%
+576.56K
+152.92%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
SPDR S&P Health Care Equipment ETF
1.78%
ROBO Global Healthcare Technology & Innovation ETF
1.68%
Invesco S&P SmallCap Health Care ETF
0.6%
Federated Hermes MDT Small Cap Core ETF
0.49%
Royce Quant Small-Cap Quality Value ETF
0.21%
Principal U.S. Small-Cap ETF
0.12%
SPDR S&P SmallCap 600 ESG ETF
0.09%
iShares S&P Small-Cap 600 Growth ETF
0.07%
SPDR S&P 600 Small Cap Growth ETF
0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.07%
查看更多
SPDR S&P Health Care Equipment ETF
占比1.78%
ROBO Global Healthcare Technology & Innovation ETF
占比1.68%
Invesco S&P SmallCap Health Care ETF
占比0.6%
Federated Hermes MDT Small Cap Core ETF
占比0.49%
Royce Quant Small-Cap Quality Value ETF
占比0.21%
Principal U.S. Small-Cap ETF
占比0.12%
SPDR S&P SmallCap 600 ESG ETF
占比0.09%
iShares S&P Small-Cap 600 Growth ETF
占比0.07%
SPDR S&P 600 Small Cap Growth ETF
占比0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
占比0.07%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
